Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion type Assertion NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_head.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion wasGeneratedBy ECO_0000203 NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion wasDerivedFrom befree-20140225 NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion SIO_000772 22576344 NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion evidence source_evidence_literature NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.
- NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_assertion description "[In the present study, we tested the utility of mouse CMV (mCMV)-based vaccines expressing human prostate-specific antigen (PSA) for prostate cancer immunotherapy in double-transgenic mice expressing PSA and HLA-DRB1*1501 (DR2bxPSA F1 mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758186.RA6qe1gK8AFJEvHIptCvw9rSoLwZa69-rECACeeizg_mk130_provenance.